Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A Decision Analytics Model to Optimize Investment in Interventions Targeting the HIV PrEP Cascade of Care

View ORCID ProfileSamuel M. Jenness, Gregory Knowlton, Dawn K. Smith, View ORCID ProfileJulia L. Marcus, View ORCID ProfileEmeli J. Anderson, View ORCID ProfileAaron J. Siegler, View ORCID ProfileJeb Jones, View ORCID ProfilePatrick S. Sullivan, View ORCID ProfileEva Enns
doi: https://doi.org/10.1101/2020.12.10.20247270
Samuel M. Jenness
1Department of Epidemiology, Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Samuel M. Jenness
  • For correspondence: samuel.m.jenness@emory.edu
Gregory Knowlton
2Division of Health Policy and Management, University of Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dawn K. Smith
3Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia L. Marcus
4Department of Population Medicine, Harvard Medical School
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julia L. Marcus
Emeli J. Anderson
1Department of Epidemiology, Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emeli J. Anderson
Aaron J. Siegler
1Department of Epidemiology, Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aaron J. Siegler
Jeb Jones
1Department of Epidemiology, Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeb Jones
Patrick S. Sullivan
1Department of Epidemiology, Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick S. Sullivan
Eva Enns
2Division of Health Policy and Management, University of Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eva Enns
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objectives Gaps between recommended and actual levels of HIV preexposure prophylaxis (PrEP) use remain among men who have sex with men (MSM). Interventions can address these gaps, but it is unknown how public health initiatives should invest prevention funds into these interventions to maximize their population impact.

Design We used a stochastic network-based HIV transmission model for MSM in the Atlanta area paired with an economic budget optimization model.

Methods The model simulated MSM participating in up to three real-world PrEP cascade interventions designed to improve initiation, adherence, or persistence. The primary outcome was infections averted over 10 years. The budget optimization model identified the investment combination under different budgets that maximized this outcome given intervention costs from a payer perspective.

Results From the base 15% PrEP coverage level, the three interventions could increase coverage to 27%, resulting in 12.3% of infections averted over 10 years. Uptake of each intervention was interdependent: maximal use of the adherence and persistence interventions depended on new PrEP users generated by the initiation intervention. As the budget increased, optimal investment involved a mixture of the initiation and persistence interventions, but not the adherence intervention. If adherence intervention costs were halved, the optimal investment was roughly equal across interventions.

Conclusions Investments into the PrEP cascade through initiatives should account for the interactions of the interventions as they are collectively deployed. Given current intervention efficacy estimates, the total population impact of each intervention may be improved with greater total budgets or reduced intervention costs.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by Centers for Disease Control and Prevention cooperative agreement number U38 PS004646 and National Institutes of Health grant R01 AI138783. Dr. Marcus is supported in part by National Institutes of Health grant K01 AI122853.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Emory University Institutional Review Board approved the study protocols for the primary empirical data collection yielding model parameters for the current study.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • FUNDING This work was supported by Centers for Disease Control and Prevention cooperative agreement number U38 PS004646 and National Institutes of Health grant R01 AI138783. Dr. Marcus is supported in part by National Institutes of Health grant K01 AI122853.

  • DISCLAIMER The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the official positions of the Centers for Disease Control and Prevention.

  • DISCLOSURES The authors declare no conflicts of interest.

  • Primary substantive update is the inclusion of further details about the economic budget optimization model in the main text and supplemental appendix.

Data Availability

The model code and parameters are all open and availability at the Github repository linked below.

https://github.com/EpiModel/PrEP-Optimize

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 01, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A Decision Analytics Model to Optimize Investment in Interventions Targeting the HIV PrEP Cascade of Care
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Decision Analytics Model to Optimize Investment in Interventions Targeting the HIV PrEP Cascade of Care
Samuel M. Jenness, Gregory Knowlton, Dawn K. Smith, Julia L. Marcus, Emeli J. Anderson, Aaron J. Siegler, Jeb Jones, Patrick S. Sullivan, Eva Enns
medRxiv 2020.12.10.20247270; doi: https://doi.org/10.1101/2020.12.10.20247270
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
A Decision Analytics Model to Optimize Investment in Interventions Targeting the HIV PrEP Cascade of Care
Samuel M. Jenness, Gregory Knowlton, Dawn K. Smith, Julia L. Marcus, Emeli J. Anderson, Aaron J. Siegler, Jeb Jones, Patrick S. Sullivan, Eva Enns
medRxiv 2020.12.10.20247270; doi: https://doi.org/10.1101/2020.12.10.20247270

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • HIV/AIDS
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (196)
  • Anesthesia (54)
  • Cardiovascular Medicine (489)
  • Dentistry and Oral Medicine (90)
  • Dermatology (56)
  • Emergency Medicine (168)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (211)
  • Epidemiology (5685)
  • Forensic Medicine (3)
  • Gastroenterology (216)
  • Genetic and Genomic Medicine (868)
  • Geriatric Medicine (88)
  • Health Economics (231)
  • Health Informatics (762)
  • Health Policy (391)
  • Health Systems and Quality Improvement (253)
  • Hematology (105)
  • HIV/AIDS (182)
  • Infectious Diseases (except HIV/AIDS) (6481)
  • Intensive Care and Critical Care Medicine (390)
  • Medical Education (117)
  • Medical Ethics (28)
  • Nephrology (93)
  • Neurology (848)
  • Nursing (44)
  • Nutrition (141)
  • Obstetrics and Gynecology (163)
  • Occupational and Environmental Health (261)
  • Oncology (514)
  • Ophthalmology (163)
  • Orthopedics (44)
  • Otolaryngology (106)
  • Pain Medicine (48)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (250)
  • Pharmacology and Therapeutics (146)
  • Primary Care Research (114)
  • Psychiatry and Clinical Psychology (967)
  • Public and Global Health (2230)
  • Radiology and Imaging (377)
  • Rehabilitation Medicine and Physical Therapy (174)
  • Respiratory Medicine (312)
  • Rheumatology (109)
  • Sexual and Reproductive Health (80)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)